142 related articles for article (PubMed ID: 37795222)
1. The outcome of early-stage glottic carcinoma patients treated with radiotherapy: Egyptian National Cancer Institute (NCI-Egypt) experience.
Mohamed AE; Hassouna AH; Mosalum HS; Alnagmy AK; Ashour MG
Rep Pract Oncol Radiother; 2023; 28(4):496-505. PubMed ID: 37795222
[TBL] [Abstract][Full Text] [Related]
2. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Radiotherapy for Patients with Early-Stage Glottic Cancer: Patterns of Care and Survival.
Bledsoe TJ; Park HS; Stahl JM; Yarbrough WG; Burtness BA; Decker RH; Husain ZA
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521361
[TBL] [Abstract][Full Text] [Related]
4. Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions.
Ermiş E; Teo M; Dyker KE; Fosker C; Sen M; Prestwich RJ
Radiat Oncol; 2015 Sep; 10():203. PubMed ID: 26395876
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
6. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Early-stage Glottic Carcinoma Treated with Radiation Therapy: A Single Institution Experience.
AlQahtani M; Maklad AM; Shuja M; AlQahtani KH; AlHussain H; AlDhahri SF; AlAmro A; Aly MM; Tunio MA; Marie A; Alkholaiwi F; Alobida N; Elghazaly AA; Bayoumi Y
Cureus; 2018 Oct; 10(10):e3444. PubMed ID: 30555759
[TBL] [Abstract][Full Text] [Related]
8. Patterns of failure for early-stage glottic carcinoma: 10 years' experience in conformal radiotherapy era.
Sert F; Kaya I; Ozturk K; Esassolak M
J Cancer Res Ther; 2019; 15(3):576-581. PubMed ID: 31169223
[TBL] [Abstract][Full Text] [Related]
9. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control.
Sakata K; Aoki Y; Karasawa K; Hasezawa K; Muta N; Nakagawa K; Terahara A; Onogi Y; Sasaki Y; Akanuma A
Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1059-64. PubMed ID: 7961012
[TBL] [Abstract][Full Text] [Related]
11. Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules.
Kim TG; Ahn YC; Nam HR; Chung MK; Jeong HS; Son YI; Baek CH
Clin Exp Otorhinolaryngol; 2012 Jun; 5(2):94-100. PubMed ID: 22737290
[TBL] [Abstract][Full Text] [Related]
12. Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: A systematic review and meta-analysis of 1762 patients.
Sapienza LG; Ning MS; Taguchi S; Calsavara VF; Pellizzon ACA; Gomes MJL; Kowalski LP; Baiocchi G
Oral Oncol; 2019 Jun; 93():8-14. PubMed ID: 31109700
[TBL] [Abstract][Full Text] [Related]
13. Clinical radiobiology of stage T2-T3 bladder cancer.
Majewski W; Maciejewski B; Majewski S; Suwinski R; Miszczyk L; Tarnawski R
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):60-70. PubMed ID: 15337540
[TBL] [Abstract][Full Text] [Related]
14. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
15. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control.
Nishimura Y; Nagata Y; Okajima K; Mitsumori M; Hiraoka M; Masunaga S; Ono K; Shoji K; Kojima H
Radiother Oncol; 1996 Sep; 40(3):225-32. PubMed ID: 8940749
[TBL] [Abstract][Full Text] [Related]
17. Three-week hypofractionated radiotherapy in early glottic cancer-a single institution retrospective study.
Sudha AS; Kumar RR; Anjanappa M; Kainickal CT; Mathew A; Kunnambath R
Ecancermedicalscience; 2022; 16():1381. PubMed ID: 35919227
[TBL] [Abstract][Full Text] [Related]
18. The value of insulin-like growth factor-1 receptor for predicting early glottic carcinoma response to radiotherapy.
Matsumoto F; Ohba S; Fujimaki M; Ikeda K
Auris Nasus Larynx; 2016 Aug; 43(4):440-5. PubMed ID: 26739949
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
[TBL] [Abstract][Full Text] [Related]
20. Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.
Burke LS; Greven KM; McGuirt WT; Case D; Hoen HM; Raben M
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):37-42. PubMed ID: 9212002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
